Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Record History

See every version on ClinicalTrials.gov ↗

1. Minor May 2, 2017 2 versions Re-verified since Feb 9, 2016, no change to tracked fieldsv6-v7
2. Notable May 27, 2015 Trial status: Active, Not Recruiting to Recruitingv5 Show 9 more changesShow less

   • Primary endpoints: 1 to 2
   • Study sites: 0 to 1
   • Primary completion date: Jan 2100
   • Start date: Sep 2004
   • Interventions: fluorescent antibody technique (Other), immunohistochemistry staining method (Other), laboratory biomarker analysis (Other) to Laboratory Biomarker Analysis (Other)
   • Eligibility criteria shortened, about 7 words
   • Secondary endpoints shortened, about 14 words
   • Study arms: 0 to 1
   • Study description expanded, about 5 words
3. Minor Jul 8, 2011 3 versions Re-verified since Oct 29, 2009, no change to tracked fieldsv2-v4
4. Minor Oct 22, 2009 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.